CB
Chetan Bipinchandra Shah
About Chetan Bipinchandra Shah
Data last updated:
Chetan Bipinchandra Shah has 2 years in corporate governance. Holds Director and Whole-Time Director roles. Currently with 3 companies, including Ratnatris Pharmaceuticals Private Limited and Senores Pharmaceuticals Limited. Formerly with 1 company. Engaged in General Business. Contributes to corporate operations. The 3 current companies with reported revenue have a combined latest revenue of ₹573 Cr; the largest is Senores Pharmaceuticals Limited at ₹418 Cr (FY 2025).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Senores Pharmaceuticals Limited L24290GJ2017PLC100263 | Whole-Time Director | 10 Nov 2023 | 2017 | ₹418 Cr (FY 2025) | Active |
 Ratnatris Pharmaceuticals Private Limited U24230GJ2005PTC047394 | Director | 14 May 2025 | 2005 | ₹142 Cr (FY 2025) | Active |
 Apnar Pharma Private Limited U73100GJ2014PTC081520 | Additional Director | 16 Jan 2026 | 2014 | ₹14.22 Cr (FY 2025) | Active |
Previous companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Ratnagene Lifescience Private Limited U24231GJ2021PTC125613 | Director | 05 Feb 2024 | 2021 | ₹1.98 Cr (FY 2023) | Amalgamated |
Explore Director's current and past company associations Uncover their professional journey today!
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Chetan Bipinchandra Shah
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Chetan Bipinchandra Shah
Chetan Bipinchandra Shah has 2 years in corporate governance. Holds Director and Whole-Time Director roles. Currently with 3 companies, including Ratnatris Pharmaceuticals Private Limited and Senores Pharmaceuticals Limited. Formerly with 1 company. Engaged in General Business. Contributes to corporate operations. The 3 current companies with reported revenue have a combined latest revenue of ₹573 Cr; the largest is Senores Pharmaceuticals Limited at ₹418 Cr (FY 2025).
Chetan Bipinchandra Shah is associated with 3 companies as Director and Whole-Time Director, including Senores Pharmaceuticals Limited (₹418 Cr), Ratnatris Pharmaceuticals Private Limited (₹142 Cr), Apnar Pharma Private Limited (₹14.22 Cr).
Chetan Bipinchandra Shah has expertise in General Business.
Chetan Bipinchandra Shah has 2 years in corporate governance.
By reported revenue, the largest current company of Chetan Bipinchandra Shah is Senores Pharmaceuticals Limited, with revenue of ₹418 Cr (FY 2025).
The 3 current companies of Chetan Bipinchandra Shah that report revenue have a combined latest revenue of ₹573 Cr.
Chetan Bipinchandra Shah currently holds positions at 3 companies: Senores Pharmaceuticals Limited (₹418 Cr), Ratnatris Pharmaceuticals Private Limited (₹142 Cr), Apnar Pharma Private Limited (₹14.22 Cr).